Andrew Gwynne – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Andrew Gwynne on 2016-02-23.
To ask the Secretary of State for Health, what assessment he has made of the effect on NHS (a) services and (b) governance of NHS England’s decision to discontinue the role of national clinical director for neurology services from March 2016; and if he will make a statement.
Jane Ellison
Sir Bruce Keogh, NHS England’s Medical Director, has undertaken a review of the National Clinical Director (NCD) resource designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement. As a result of the review, NHS England has proposed to change the way in which clinical advice is received in speciality areas in the future.
Where there will no longer be a specific NCD role, NHS England will secure expert clinical advice from its clinical networks and through its relationships with professional bodies and by appointing clinical advisors. For neurology it is planned that access to advice will be through clinical leads and members of the NHS England-funded neurology clinical networks, the Neurology Clinical Reference Group and Royal Colleges. It is expected that these new arrangements will be in place from 1 April 2016.
